Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-07-19
1990-12-11
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514415, 548486, A01N 4338, C07D20934
Patent
active
049771787
ABSTRACT:
Certain substituted 1-phenyl-3-(aminoalkylidene)-2(1H,3H)-indolones are highly potent gabaergic agents, valuable in the treatment of individuals suffering from schizophrenia or reversing the side effects of a previously or concurrently administered neuroleptic agent; or in the treatment of epilepsy. A wider class of substituted 1-phenyl-3-(aminoalkylidene)-2(1H,3H)-indolones, together with 1-phenyl-3-(2-pyrrolidinylidene)-2(1H,3H)-indolones, and homologs thereof, are valuable in the treatment of anxiety.
REFERENCES:
patent: 3043849 (1962-07-01), Szmuszkovicz
patent: 3215699 (1965-02-01), Shavel et al.
patent: 3496275 (1970-02-01), Thominet
patent: 3506683 (1970-04-01), Anthony et al.
patent: 3642803 (1972-02-01), Welstead
patent: 3644403 (1972-02-01), Canas-Rodriguez et al.
patent: 4006161 (1977-02-01), Holmes et al.
patent: 4145422 (1979-03-01), Winn et al.
patent: 4332804 (1982-06-01), Clark
patent: 4624963 (1986-11-01), Kruse et al.
Howard, Jr. Harry R.
Sarges Reinhard
Blackwood Robert K.
Cashion Jr. Merrell C.
Kishore G. S.
Lumb J. Trevor
Pfizer Inc.
LandOfFree
Method of treating anxiety and depression with 1-phenyl-2(1H,3H) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating anxiety and depression with 1-phenyl-2(1H,3H), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating anxiety and depression with 1-phenyl-2(1H,3H) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-390589